Doxycycline in Type II Diabetes
Conditions: Diabetes Mellitus, Type 2 Interventions: Drug: Sitagliptin 100mg; Drug: Doxycyclin Sponsors: Mostafa Bahaa Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
Comparative Study of Metformin Versus Doxycycline in Moderate to Severe Adult Acne Vulgaris Patients.
Conditions: Acne Vulgaris Interventions: Drug: Metformin and doxycycline Sponsors: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 9, 2024 Category: Research Source Type: clinical trials
Doxycycline PEP and 4CMenB as a Comprehensive Prevention Strategy in MSM and TGW at High Risk for Bacterial STIs Within the Swiss HIV Cohort Study
Conditions: Doxycycline STI PEP Sponsors: University of Zurich; Swiss HIV Cohort Study Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials
Azithromycin Versus Doxycycline on Restistin Level in Periodontitis Patients With Type 2 Diabetes
Conditions: Periodontal Diseases; Type 2 Diabetes Interventions: Drug: Group I; Drug: Group II; Drug: Group III Sponsors: King Abdulaziz University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials
Superiority of On-demand PrEP Versus PEP on Using Doxycycline for Preventing STI in MSM
Conditions: Sexually Transmitted Diseases, Bacterial; Syphilis; Gonorrhea; Chlamydia Interventions: Drug: DoxyODPrEP; Drug: DoxyPEP Sponsors: Chinese University of Hong Kong Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 3, 2024 Category: Research Source Type: clinical trials
Anti-microbial Role of Non-antibiotic Agents Against Cutibacterium Acnes in Patients With Acne Vulgaris
Conditions: Acne Vulgaris Interventions: Diagnostic Test: assess the possible role of Salicylic acid, Isotretinoin, and N-acetylcysteine in improving the susceptibility of C. acne for Azithromycin and Doxycycline. Sponsors: Zagazig University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 21, 2023 Category: Research Source Type: clinical trials
In-vivo Transmission Model in Semi-immune Adults
Conditions: Controlled Human Malaria Infection; Induced Blood Stage Malaria Infection; Malaria Transmission; Malaria Challenge Interventions: Drug: Piperaquine tablets , which will be administered orally as a single dose of 480mg (320mg+160mg).; Drug: Doxycycline (100mg tablets strength as Doxycycline Hyclate) will also be administered orally and will be given as 1 tablet (100mg) Once daily for 7 days. Sponsors: Ifakara Health Institute; University of Oxford Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2023 Category: Research Source Type: clinical trials
Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib
Conditions: Carcinoma, Non-Small-Cell Lung Interventions: Drug: Amivantamab; Drug: Lazertinib; Drug: Doxycycline; Drug: Minocycline; Drug: Clindamycin; Drug: Chlorhexidine; Other: Noncomedogenic skin moisturizer Sponsors: Janssen Research& Development, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 7, 2023 Category: Research Source Type: clinical trials
Cefixime 800 mg Plus Doxycycline 100 mg b.i.d. for 7 Days Compared to Ceftriaxone 1 g Plus Azithromycin 2 g for Treatment of Urogenital, Rectal and Pharyngeal Gonorrhoea
Conditions: Gonorrhea Interventions: Drug: Cefixime; Drug: Doxycyclin; Drug: Ceftriaxon; Drug: Azithromycin Sponsors: Bulovka Hospital; Örebro University, Sweden Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2023 Category: Research Source Type: clinical trials
Cefixime Plus Doxycycline Compared to Ceftriaxone Plus Azithromycin for Treatment of Gonorrhoea
Conditions: Gonorrhea Interventions: Drug: Cefixime; Drug: Doxycyclin; Drug: Ceftriaxon; Drug: Azithromycin Sponsors: Bulovka Hospital; Örebro University, Sweden Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2023 Category: Research Source Type: clinical trials
Comparisons of Treatment Responses of Early Syphilis to Benzathine Penicillin G With or Without Doxycycline
Conditions: Early Syphilis, Latent, Serological Relapse After Treatment Interventions: Drug: Benzathine Penicillin G; Drug: Doxycycline Capsule Sponsors: National Taiwan University Hospital; National Taiwan University Hospital Hsin-Chu Branch; National Taiwan University Hospital, Yun-Lin Branch; Far Eastern Memorial Hospital; Taipei Veterans General Hospital, Taiwan; Taoyuan General Hospital; China Medical University Hospital; National Cheng-Kung University Hospital; Chi Mei Medical Hospital; Chiayi Christian Hospital; Kaohsiung Medical University Chung-Ho Memorial Hospital; Kaohsiung Veterans General Hospital. Not yet rec...
Source: ClinicalTrials.gov - October 5, 2023 Category: Research Source Type: clinical trials
Postexposure Prophylaxis With Single Dose Doxycycline for the Prevention of Tick-borne Relapsing Fever
Condition: Postexposure Prophylaxis With Single Dose Doxycycline for the Prevention of Tick-borne Relapsing Fever Intervention: Drug: administration of single dose of doxycycline Sponsor: Medical Corps, Israel Defense Force Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
